Skip to content

Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application

A Fortune 500 pharmaceutical company approached SR about testing a prophylactic molecule in reducing or preventing influenza infection in a ferret model.

Cover of Case Study: Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application
Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application
Therapeutic Areas: IDR
Capabilities: Animal Models

Related Resources

Related Resource block to be added later.

Ready to Advance Your Research?

Contact our experts today and explore how Southern Research can elevate your project.